The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global cell counting market grew at a CAGR of 6% during 2015-2020. Cell counting refers to a technique used for the analysis of the cells or micelles that are usually suspended in blood or other body fluids. Some of the common instruments used for cell counting includes hemocytometers, spectrophotometers, flow cytometers, automated cell counters, etc. Cell counting aids in classifying cell types and detecting disease through probes to develop the best treatment plan for the patient. It also helps in understanding the structure and composition of the cells for chromosome analysis, protein expression, cancer diagnosis, hematological malignancies, etc. As a result, cell counting is extensively used across hospitals, diagnostic laboratories, research and academic institutes, pharmaceutical and biotechnology companies, etc.
The rising prevalence of various chronic ailments, such as cancer, HIV-AIDS, leukemia, Alzheimer’s, etc., is propelling the demand for cell counting techniques. Moreover, the growing adoption of cell counting instruments across diverse medical fields, such as molecular biology, immunology, pathology, etc., for developing next-generation therapeutics is also augmenting the market growth. In addition to this, the increasing utilization of cell counting for the identification and determination of primary tumor, circulating tumor, and metastatic tumor is further bolstering the market growth. Additionally, the widespread adoption of stem cell therapy is also propelling the demand for various cell counting instruments on a global level. In line with this, the rising awareness towards numerous benefits of cell counting technique in immunophenotyping, cell sorting, cell proliferation assays and intracellular calcium flux is further driving the market growth. Moreover, the increasing investments by several government bodies in extensive R&D activities pertaining to the fields of biotechnology, oncology stem cell therapeutics, etc., are also bolstering the adoption of cell counting techniques. In the coming years, the introduction of automated product variants with enhanced ability to process larger sample sizes at a higher speed will continue to drive the global market for cell counting. Looking forward, IMARC Group expects global cell counting market to exhibit moderate growth during the next five years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global cell counting market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product type and end-user.
Breakup by Product Type:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd. (Roche Holding AG)., Merck & Co. Inc., PerkinElmer Inc. and Thermo Fisher Scientific Inc.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at